BREAKING: US Trials of Oxfords Coronavirus Vaccine Allowed to RESUME

The FDA will let US trials of AstraZeneca and Oxford’s coronavirus vaccine RESUME weeks after it was paused over a rare ‘spinal problem’ in a UK participant.

According to documents obtained by the Wall Street Journal, US regulators have announced that AstraZeneca can resume the US arm of its trial of Oxford University’s coronavirus vaccine. AstraZeneca paused global trials on September 8 due to what it called at the time an ‘unexplained illness’ in a British volunteer. 

Tests resumed on September 8 in the UK, but US Food and Drug Administration (FDA) officials decided to conduct their own independent investigation, finally agreeing to continuation of the trials on Wednesday.

Meanwhile, a participant in the Brazil arm of the trial died on Wednesday, but Oxford University determined that there was ‘no safety concern’ over the vaccine and related to the death and international trials are up and running again.

Thank you for taking the time to read this news article “US Trials of Oxfords Coronavirus Vaccine Allowed to RESUME”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

Euro Weekly News is delighted to continue to be able to bring you a range of News from around Spain in English and Global News live as it happens.

Euro Weekly News doesn’t cost you anything but your internet connection. Whether it’s bringing you the local Spanish news or the International news today, we’ve got you covered!

Euro Weekly News, the leading free local and national newspaper in Spain, the people’s paper, we lead others follow!    

Author badge placeholder
Written by

Tony Winterburn

Share your story with us by emailing, by calling +34 951 38 61 61 or by messaging our Facebook page